SUMMARY A selective subtotal cerebellar neuronal degeneration was found in a patient who died 41 months after suffering neuroleptic malignant syndrome (NMS), a rare, potentially fatal disorder associated with neuroleptic medications. It is suggested that the cerebellar neuronal degeneration in this case was due to hyperpyrexia, a cardinal clinical feature of NMS. Similar pathologic findings appear not to have been previously reported in NMS but have been described in heat-induced central nervous system (CNS) injury. The findings imply that a cerebellar syndrome might be encountered in patients who survive NMS complicated by a particularly high febrile course.
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Neuroleptic malignant syndrome (NMS) is a potentially lethal reaction to central dopamine blocking agents.' It is characterised clinically by hyperpyrexia, extrapyramidal rigidity, autonomic dysfunction, and depressed sensorium. Elevation of serum creatinine kinase (CK) secondary to rhabdomyolysis, abnormal liver function tests, and leukocytosis are common accompaniments. The disorder is rare, with an estimated incidence of 04 to 1-4%, and carries a fatality rate of 4 to 22% in reported series. 2 The pathogenesis of the disorder remains speculative. The current theory of the pathophysiological mechanism is extreme blockade of dopamine receptors in both the basal ganglia and hypothalamus resulting in extrapyramidal muscle rigidity with thermogenesis and in impaired central temperature regulation, respectively. Although on initial presentation to the emergency room the patient was alert and afebrile, he became progressively more rigid and mute over the next several hours as his temperature climbed to 40-1°C. On examination, the patient was tachycardic to 120 beats/min, with a blood pressure of 140/90 mm Hg and respiration of 36/min. His chest was clear to auscultation and percussion, and his abdomen was soft; he had no lymphadenopathy, skin rash, or other signs of infection. The neurological examination showed him to be initially fully oriented but he soon lapsed into a mute, stuporous state shortly after arrival in the emergency room. His optic discs were flat and the cranial nerve examination showed no abnormalities. He showed continuous dystonic posturing and choreiform movements of all four extremities. Muscle tone was increased, particularly in the lower extremities. The deep tendon reflexes were diffusely hyperactive with sustained ankle clonus. The Babinski sign was absent bilaterally.
The routine admission laboratory studies showed a leukocytosis of 16,200/mm3, with a normal differential. The creatinine kinase was 1,420 U/L initially and rose to 32,000 U/L two days later; MB fraction was 0%. A chest radiograph was normal. Non-contrast CT of the head was normal. The cerebrospinal fluid was acellular and sterile, with a protein of 26 mg/100 ml and a glucose of 91 mg/100 ml. A diagnosis of neuroleptic malignant syndrome (NMS) was made, and an intravenous infusion ofdantrolene 160 mg was administered, along with bromocriptine 2 5 mg by nasogastric tube. The patient responded by exhibiting less muscular hypertonia, by becoming aware of his environment, and by defervescing to 37 7°C.
The following day his muscle rigidity returned and his temperature rose to 38 8°C. Dantrolene was readministered, but the infusion was interrupted after 120 mg was administered when the patient suddenly developed bradycardia (47/ min) and hypotension (70 mmHg/palpation). He became unresponsive to verbal stimuli, became flaccid, and required mechanical ventilation. An EEG showed diffuse slowing with delta and theta waves, with no lateralising or epileptiform features. Neither dantrolene nor bromocriptine were readministered. (fig a & b) . There was almost complete loss of Purkinje cells, moderate reduction of granular neurons, and subtotal loss ofneurons in the dentate nucleus. Proliferating Bergmann's glia replaced the Purkinje cell layer, and were diffusely scattered throughout the thinned molecular layer. The cerebellar white matter was pale, vacuolated, and infiltrated by numerous macrophages that were most concentrated in the core of folia, deep white matter, and adjacent to the dentate nucleus. The macrophages contained myelin debris that stained blue with luxolfast-blue (LFB). The white matter demonstrated loss of myelin and axons on LFB and Bodian's stain. Similarly, the superior cerebellar peduncle (SCP) and the dentatorubrothalamic tract from the dentate hilum to the ventral thalamus displayed degeneration of axons and myelin associated with lipid-laden macrophages, characteristic of active Wallerian degeneration (fig c & d) . The fibre tract degeneration was not present in other myelinated pathways and the cerebral white matter was free of similar degeneration.
The cerebral cortex, basal ganglia, and hippocampus were free of anoxic-ischaemic changes. Neither dark shrunken neurons nor neuronal loss were seen in any ofthe areas. Serial sections of hypothalamus taken at 3 mm intervals from the olfactory trigone to the level of pulvinar were free of significant changes. The spinal cord was also unremarkable.
The cerebrum, brainstem, and cerebellum had scattered microabscesses of various ages in which rare yeasts with pseudohyphae consistent with candida were demonstrated.
The muscles (deltoid and pectoralis major) were histologically abnormal. Randomly scattered atrophic fibres were focally surrounded by increased endomysial connective tissue. Enzyme histochemical preparations performed on frozen sections identified the atrophic fibres to be predominantly type II.
Discussion
Neuroleptic malignant syndrome (NMS), a rare complication of neuroleptic treatment, is fatal in up to 22% of cases.2 Hyperpyrexia to a toxic degree (over 40"C) has been recorded in about a third of patients with NMS in one series.2 Neuropathological studies have been few, and to our knowledge, no cases sinilar to ours have previously been reported. The present patient suffered schizophrenia for many years and had received multiple neuroleptics including several phenothiazines and haloperidol, a butyrophenone. Both groups are implicated in inducing NMS, the latter with a higher frequency. Our patient had additionally been maintained on tetrabenazine, a dopamine blocking and depleting agent used to treat movement disorders. Tetrabenazine has also been shown to cause NMS.8 The NMS in our patient developed soon after the neuroleptic dose was increased, a previously reported pattern.2
Neuroleptic drugs predispose to hyperpyrexia by their anticholinergic properties, which block sweating and heat dissipation, and by their antidopaminergic properties, which interfere with hypothalamic thermoregulation.>" When an abrupt catastrophic disorder associated with hyperpyrexia occurs in a patient taking neuroleptics, the clinician must distinguish heat stroke from NMS. Neuroleptic-induced heat stroke can be differentiated from NMS by the absence of extrapyramidal signs, absence of diaphoresis, and a history of physical exercise or exposure to high ambient temperature.2 A permanent cerebellar syndrome has been reported in a patient with neuroleptic-induced heat stroke,9 but a pathological correlate was not described. Most In neuropathological studies of hyperpyrexia,'61924 the most common CNS abnormalities were oedema, congestion, and haemorrhages, particularly in th~e vicinity of third and fourth ventricles, and in the white matter. It was felt that these non-specific alterations were related to terminal shock or circulatory collapse that accompanied hyperpyrexia, since the severity and distribution of these lesions were similar to the changes in shock not associated with hyperpyrexia.
The parenchymal injury due to hyperpyrexia per se was most striking and constant in the cerebellum. In those cases where death occurred after more than a week, the Purkinje cells were almost entirely lost, and the neurons of the deep cerebellar nuclei were also injured. With shorter survivals, however, the Purkinje cell changes were more subtle, consisting of neuronal swelling, pyknosis, or focal drop out. Interestingly, the cerebral cortex and basal ganglia were less frequently and only focally involved. This is in contrast to hypoxic CNS injury, in which selective vulnerability is shared among neurons in different regions of the brain including cerebral cortex, hippocampal Sommer's sector, cerebellum, and basal ganglia. 26 The physical and biochemical properties that are the basis of this selective vulnerability of cerebellar neurons to heat-induced injuries are not completely known. It has been shown, however, that preferential degeneration of cerebellar neurons can be induced by heat stress in animals.2' It has also been shown that certain cells, such as established cancer cell lines, differ in their expression of heat shock protein during heat stress2" implying that response to heat stress is to some extent a function ofcell type. Recent in situ hybridisation studies of heat shock protein expression in the brains of rabbits have demonstrated heat shock gene induction in the cerebellar neurons, in the absence of similar changes in neurons ofother parts ofthe brain.28 This would further indicate that cerebellar neurons are unique in their response to heat stress.
